{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketPrice": 0.679, "exchange": "FRA", "shortName": "9 METERS BIOPHARM.DL-,001", "longName": "9 Meters Biopharma, Inc.", "messageBoardId": "finmb_281083548", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.0908382, "firstTradeDateMilliseconds": 1525932000000, "priceHint": 4, "regularMarketChange": -0.014499962, "regularMarketTime": 1683871215, "regularMarketDayHigh": 0.679, "regularMarketDayRange": "0.679 - 0.679", "regularMarketDayLow": 0.679, "regularMarketVolume": 900, "regularMarketPreviousClose": 0.6935, "bid": 0.6835, "ask": 0.707, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.679, "averageDailyVolume3Month": 195, "averageDailyVolume10Day": 430, "fiftyTwoWeekLowChange": 0.055999994, "fiftyTwoWeekLowChangePercent": 0.08988763, "fiftyTwoWeekRange": "0.623 - 12.2", "fiftyTwoWeekHighChange": -11.521, "fiftyTwoWeekHighChangePercent": -0.9443443, "fiftyTwoWeekLow": 0.623, "fiftyTwoWeekHigh": 12.2, "earningsTimestamp": 1680005220, "earningsTimestampStart": 1684148400, "earningsTimestampEnd": 1684494000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.4, "sharesOutstanding": 14336400, "bookValue": 0.184, "fiftyDayAverage": 1.20021, "fiftyDayAverageChange": -0.52120996, "fiftyDayAverageChangePercent": -0.43426564, "twoHundredDayAverage": 2.5552, "twoHundredDayAverageChange": -1.8762001, "twoHundredDayAverageChangePercent": -0.73426735, "marketCap": 10311430, "priceToBook": 3.6902175, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "2Q3A.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4509 Creedmoor Road", "address2": "Suite 201", "city": "Raleigh", "state": "NC", "zip": "27612", "country": "United States", "phone": "919 275 1933", "website": "https://www.9meters.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders in North America. Its lead product candidate is Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 3 clinical trial to treat short bowel syndrome. The company is developing NM-136, a humanized monoclonal antibody for the treatment of obesity and obesity-related disorders; NM-102, a small molecule peptide to prevent antigens from trafficking into systemic circulation; and NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease. Its partnered product is Larazotide, an 8-amino acid peptide, which is in Phase 2 clinical trial for treatment of multi-system inflammatory syndrome. The company has licensing agreements with Amunix, MHS Care Innovation LLC, Alba Therapeutics Corporation, and EBRIS. 9 Meters Biopharma, Inc. is headquartered in Raleigh, North Carolina.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. John  Temperato", "age": 57, "title": "Pres, CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 553213, "fmt": "553.21k", "longFmt": "553,213"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Bethany  Sensenig C.M.A., M.B.A.", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 525588, "fmt": "525.59k", "longFmt": "525,588"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sireesh  Appajosyula Pharm.D.", "age": 46, "title": "Sr. VP of Corp. Devel. & Operations", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Albert J. Medwar M.B.A., MBA", "title": "Sr. VP of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nir  Barak M.D.", "title": "Sr. VP of Scientific Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter H. R. Green M.D.", "title": "Clinical & Scientific Advisor and Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joseph A. Murray M.D.", "title": "Clinical & Scientific Advisor and Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ciaran P. Kelly M.D.", "title": "Clinical & Scientific Advisor and Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Elena  Verdu M.D., Ph.D.", "title": "Clinical & Scientific Advisor and Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Markku  M\u00e4ki M.D., Ph.D.", "title": "Clinical & Scientific Advisor and Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}